Use of Tissue Plasminogen Activator in the Clearance of Chronic Subdural Hematomas
Clinical trial NCT05491356 · COMPLETED
Trial details
- NCT number
- NCT05491356
- Sponsor
- Hamilton Health Sciences Corporation
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-11
- Primary completion
- 2024-03-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.